VERU INC. Cost of Goods Sold (Deprecated 2018-01-31)
VERU INC. (VERU) reported Cost of Goods Sold (Deprecated 2018-01-31) of $2.42 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-08-14
- VERU INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $2.42M, a 20.06% increase year-over-year.
- VERU INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.37M, a 21.78% increase year-over-year.
- VERU INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.27M, a 20.03% decline year-over-year.
- VERU INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.90M, a 11.99% increase year-over-year.
- VERU INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $6.64M, a 24.40% decline from fiscal 2016.
- VERU INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $8.78M, a 35.62% decline from fiscal 2015.
- VERU INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $13.63M, a 19.93% increase from fiscal 2014.
- VERU INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $11.37M, a 18.52% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $2.42M 10-Q · filed 2018-08-14 | $3.80M derived: sum of 2 quarters · filed 2018-08-14 | $5.07M 10-Q · filed 2018-08-14 | $6.97M derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | $1.37M 10-Q · filed 2018-05-11 | $2.65M 10-Q · filed 2018-05-11 | $4.54M derived: sum of 3 quarters · filed 2018-05-11 | $6.56M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-12-31 | $1.27M 10-Q · filed 2018-02-14 | $3.17M derived: sum of 2 quarters · filed 2018-02-14 | $5.19M derived: sum of 3 quarters · filed 2018-08-14 | $6.32M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-09-30 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $3.92M derived: sum of 2 quarters · filed 2018-08-14 | $5.04M derived: sum of 3 quarters · filed 2018-08-14 | $6.64M 10-K · filed 2018-01-02 |
| 2017-06-30 | $2.02M 10-Q · filed 2018-08-14 | $3.15M derived: sum of 2 quarters · filed 2018-08-14 | $4.74M 10-Q · filed 2018-08-14 | $6.43M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $1.13M 10-Q · filed 2018-05-11 | $2.72M 10-Q · filed 2018-05-11 | $4.41M derived: sum of 3 quarters · filed 2018-05-11 | $6.74M derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $1.59M 10-Q · filed 2018-02-14 | $3.29M derived: sum of 2 quarters · filed 2018-02-14 | $5.61M derived: sum of 3 quarters · filed 2018-02-14 | $7.54M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $4.02M derived: sum of 2 quarters · filed 2018-01-02 | $5.95M derived: sum of 3 quarters · filed 2018-01-02 | $8.78M 10-K · filed 2018-01-02 |
| 2016-06-30 | $2.33M 10-Q · filed 2017-08-09 | $4.25M derived: sum of 2 quarters · filed 2017-08-09 | $7.08M 10-Q · filed 2017-08-09 | $10.11M derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-03-31 | $1.93M 10-Q · filed 2017-05-10 | $4.76M 10-Q · filed 2017-05-10 | $7.79M derived: sum of 3 quarters · filed 2018-01-02 | $10.97M derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-12-31 | $2.83M 10-Q · filed 2017-02-09 | $5.86M derived: sum of 2 quarters · filed 2018-01-02 | $9.04M derived: sum of 3 quarters · filed 2018-01-02 | $13.62M derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-09-30 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $6.21M derived: sum of 2 quarters · filed 2018-01-02 | $10.80M derived: sum of 3 quarters · filed 2018-01-02 | $13.63M 10-K · filed 2018-01-02 |
| 2015-06-30 | $3.18M 10-Q · filed 2016-07-28 | $7.76M derived: sum of 2 quarters · filed 2016-07-28 | $10.60M 10-Q · filed 2016-07-28 | $13.27M derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | $4.58M 10-Q · filed 2016-04-28 | $7.42M 10-Q · filed 2016-04-28 | $10.09M derived: sum of 3 quarters · filed 2016-12-12 | $13.82M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | $2.84M 10-Q · filed 2016-02-02 | $5.51M derived: sum of 2 quarters · filed 2016-12-12 | $9.24M derived: sum of 3 quarters · filed 2016-12-12 | $11.20M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $6.40M derived: sum of 2 quarters · filed 2016-12-12 | $8.36M derived: sum of 3 quarters · filed 2016-12-12 | $11.37M 10-K · filed 2016-12-12 |
| 2014-06-30 | $3.73M 10-Q · filed 2015-07-30 | $5.69M derived: sum of 2 quarters · filed 2015-07-30 | $8.70M 10-Q · filed 2015-07-30 | $11.22M derived: sum of 4 quarters · filed 2015-12-02 |
| 2014-03-31 | $1.96M 10-Q · filed 2015-04-30 | $4.97M 10-Q · filed 2015-04-30 | $7.49M derived: sum of 3 quarters · filed 2015-12-02 | $11.02M derived: sum of 4 quarters · filed 2015-12-02 |
| 2013-12-31 | $3.01M 10-Q · filed 2015-02-03 | $5.53M derived: sum of 2 quarters · filed 2015-12-02 | $9.06M derived: sum of 3 quarters · filed 2015-12-02 | $13.02M derived: sum of 4 quarters · filed 2015-12-02 |
| 2013-09-30 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | $6.05M derived: sum of 2 quarters · filed 2015-12-02 | $10.01M derived: sum of 3 quarters · filed 2015-12-02 | $13.95M 10-K · filed 2015-12-02 |
| 2013-06-30 | $3.54M 10-Q · filed 2014-07-31 | $7.49M derived: sum of 2 quarters · filed 2014-07-31 | $11.44M 10-Q · filed 2014-07-31 | $15.60M derived: sum of 4 quarters · filed 2014-12-02 |
| 2013-03-31 | $3.96M 10-Q · filed 2014-05-01 | $7.90M 10-Q · filed 2014-05-01 | $12.06M derived: sum of 3 quarters · filed 2014-12-02 | $15.42M derived: sum of 4 quarters · filed 2014-12-02 |
| 2012-12-31 | $3.94M 10-Q · filed 2014-02-03 | $8.11M derived: sum of 2 quarters · filed 2014-12-02 | $11.47M derived: sum of 3 quarters · filed 2014-12-02 | $14.74M derived: sum of 4 quarters · filed 2014-12-02 |
| 2012-09-30 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $7.52M derived: sum of 2 quarters · filed 2014-12-02 | $10.79M derived: sum of 3 quarters · filed 2014-12-02 | $14.41M 10-K · filed 2014-12-02 |
| 2012-06-30 | $3.36M 10-Q · filed 2013-08-01 | $6.63M derived: sum of 2 quarters · filed 2013-08-01 | $10.25M 10-Q · filed 2013-08-01 | $13.13M derived: sum of 4 quarters · filed 2013-12-03 |
| 2012-03-31 | $3.27M 10-Q · filed 2013-05-02 | $6.89M 10-Q · filed 2013-05-02 | $9.77M derived: sum of 3 quarters · filed 2013-12-03 | $11.47M derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-12-31 | $3.62M 10-Q · filed 2013-01-30 | $6.50M derived: sum of 2 quarters · filed 2013-12-03 | $8.20M derived: sum of 3 quarters · filed 2013-12-03 | $10.68M derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-09-30 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $4.59M derived: sum of 2 quarters · filed 2013-12-03 | $7.07M derived: sum of 3 quarters · filed 2013-12-03 | $8.70M 10-K · filed 2013-12-03 |
| 2011-06-30 | $1.70M 10-Q · filed 2012-07-31 | $4.18M derived: sum of 2 quarters · filed 2012-07-31 | $5.82M 10-Q · filed 2012-07-31 | $9.02M derived: sum of 4 quarters · filed 2012-12-04 |
| 2011-03-31 | $2.48M 10-Q · filed 2012-05-01 | $4.11M 10-Q · filed 2012-05-01 | $7.31M derived: sum of 3 quarters · filed 2012-12-04 | $8.13M derived: sum of 4 quarters · filed 2012-12-04 |
| 2010-12-31 | $1.63M 10-Q · filed 2012-01-31 | $4.83M derived: sum of 2 quarters · filed 2012-12-04 | $5.65M derived: sum of 3 quarters · filed 2012-12-04 | |
| 2010-09-30 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $4.01M derived: sum of 2 quarters · filed 2012-12-04 | $9.30M 10-K · filed 2012-12-04 | |
| 2010-06-30 | $814.76K 10-Q · filed 2011-08-05 | $6.10M 10-Q · filed 2011-08-05 | ||
| 2009-09-30 | $14.03M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |